FDA delaying decision on Moderna COVID-19 vaccine for ages 12-17 due to heart inflammation concerns

The Wall Street Journal reports that the FDA may delay its decision of whether to expand authorization of the Moderna Covid vaccine by a few weeks due to myocarditis concerns.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news